Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

NCT05551624 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet

Sponsor

Hospital Civil de Guadalajara